Karalis V - Search Results

1

Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1.

Maltezou HC, Drakoulis N, Siahanidou T, Karalis V, Zervaki E, Dotsikas Y, Loukas YL, Theodoridou M. Maltezou HC, et al. Among authors: karalis v. Pediatr Infect Dis J. 2012 May;31(5):527-9. doi: 10.1097/INF.0b013e3182472f28. Pediatr Infect Dis J. 2012. PMID: 22209917

2

Contact allergy caused by acrylates in nail cosmetics: A pilot study from Greece.

Gkousiaki M, Karalis VD, Kyritsi A, Almpani C, Geronikolou S, Stratigos A, Rallis MC, Tagka A. Gkousiaki M, et al. Among authors: karalis vd. Contact Dermatitis. 2024 Mar;90(3):273-279. doi: 10.1111/cod.14485. Epub 2024 Jan 2. Contact Dermatitis. 2024. PMID: 38164086

3

An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence.

Karalis VD. Karalis VD. Pharmaceuticals (Basel). 2023 May 10;16(5):725. doi: 10.3390/ph16050725. Pharmaceuticals (Basel). 2023. PMID: 37242508 Free PMC article.

4

Joint use of population pharmacokinetics and machine learning for optimizing antiepileptic treatment in pediatric population.

Damnjanović I, Tsyplakova N, Stefanović N, Tošić T, Catić-Đorđević A, Karalis V. Damnjanović I, et al. Among authors: karalis v. Ther Adv Drug Saf. 2023 Jun 21;14:20420986231181337. doi: 10.1177/20420986231181337. eCollection 2023. Ther Adv Drug Saf. 2023. PMID: 37359445 Free PMC article.

5

Preservative contact allergy in occupational dermatitis: a machine learning analysis.

Kyritsi A, Tagka A, Stratigos A, Karalis V. Kyritsi A, et al. Among authors: karalis v. Arch Dermatol Res. 2024 Jun 8;316(7):372. doi: 10.1007/s00403-024-03101-1. Arch Dermatol Res. 2024. PMID: 38850385

6

Hematocrit effect on dried blood spots in adults: a computational study and theoretical considerations.

Daousani C, Karalis V, Malenović A, Dotsikas Y. Daousani C, et al. Among authors: karalis v. Scand J Clin Lab Invest. 2019 Sep;79(5):325-333. doi: 10.1080/00365513.2019.1622033. Epub 2019 Jun 1. Scand J Clin Lab Invest. 2019. PMID: 31154908

7

Dried Blood Spots in Neonatal Studies: A Computational Analysis for the Role of the Hematocrit Effect.

Daousani C, Karalis V, Loukas YL, Schulpis KH, Alexiou K, Dotsikas Y. Daousani C, et al. Among authors: karalis v. Pharmaceuticals (Basel). 2023 Aug 10;16(8):1126. doi: 10.3390/ph16081126. Pharmaceuticals (Basel). 2023. PMID: 37631041 Free PMC article.

8

Paediatric Medicines: Regulatory and Scientific Issues.

Daousani C, Karalis VD. Daousani C, et al. Drug Res (Stuttg). 2017 Jul;67(7):377-384. doi: 10.1055/s-0043-109788. Epub 2017 May 18. Drug Res (Stuttg). 2017. PMID: 28521373 Review.

9

Optimization of hydroxychloroquine dosing scheme based on COVID-19 patients' characteristics: a review of the literature and simulations.

Karatza E, Ismailos G, Marangos M, Karalis V. Karatza E, et al. Among authors: karalis v. Xenobiotica. 2021 Feb;51(2):127-138. doi: 10.1080/00498254.2020.1824301. Epub 2020 Sep 30. Xenobiotica. 2021. PMID: 32933365 Free PMC article. Review.

10

Pharmacodynamic considerations in bioequivalence assessment: comparison of novel and existing metrics.

Karalis V, Macheras P. Karalis V, et al. Eur J Pharm Sci. 2003 May;19(1):45-56. doi: 10.1016/s0928-0987(03)00064-2. Eur J Pharm Sci. 2003. PMID: 12729861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters